ENTA

Enanta Pharmaceuticals, Inc. News Headlines

$51.15
*  
2.11
4.3%
Get ENTA Alerts
*Delayed - data as of Dec. 26, 2014 12:17 ET  -  Find a broker to begin trading ENTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENTA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie)
12/24/2014 9:03:02 AM - Motley Fool


AbbVie Inc. Throws First Punch in Hep C Price War With Gilead Sciences, Inc.
12/23/2014 9:19:03 AM - Motley Fool


Enanta Is The Big Winner In The Hepatitis C War Between AbbVie And Gilead
12/23/2014 8:47:00 AM - Seeking Alpha


JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News


FDA Okays AbbVie's Viekira Pak To Treat Hepatitis C
12/19/2014 6:49:00 PM - RTT News


Tiger Media Agrees To Acquire Interactive Data - Quick Facts
12/15/2014 8:19:00 AM - RTT News


1 Big FDA Decision I'm Watching This Month
12/4/2014 9:15:09 AM - Motley Fool


5 Stocks to Watch Closely for the Rest of 2014
12/1/2014 11:02:16 AM - InvestorPlace Media


2nd Half Of 2014 Biotechnology Catalysts: Part 5
12/1/2014 9:59:00 AM - Seeking Alpha


Very Exciting Days Are In Store For Enanta Stockholders
11/27/2014 10:00:00 AM - Seeking Alpha


Company News for November 25, 2014 - Corporate Summary
11/25/2014 10:10:00 AM - Zacks.com


Can Partnering To Fight Hepatitis C Pay At Enanta?
11/24/2014 4:44:00 PM - Investor's Business Daily


Enanta Pharma Loss Narrower Than Estimates, Revenue Misses
11/24/2014 11:20:00 AM - RTT News


Health Care Sector Update for 11/24/2014: TTPH, ENTA
11/24/2014 9:27:36 AM - MT Newswires


Enanta And AbbVie's ABT-450 Likely To Receive FDA Approval
11/18/2014 11:13:00 AM - Seeking Alpha


Gilead presents Harvoni data
11/11/2014 11:03:00 AM - Seeking Alpha


Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha


Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
11/7/2014 8:45:02 AM - Motley Fool


AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend - Analyst Blog
10/21/2014 3:32:00 PM - Zacks.com


ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape
10/21/2014 7:44:00 AM - Zacks.com


Enanta Not To Exercise Co-development Option For ABT-493 - Update
10/21/2014 12:01:00 AM - RTT News


Enanta Not To Exercise Co-development Option For ABT-493
10/20/2014 6:24:00 PM - RTT News


End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies
10/20/2014 7:40:00 AM - Seeking Alpha


A Harvoni Vs. Olysio Price War Will Be Nonexistent: Consider Buying Gilead Now
10/17/2014 1:54:00 PM - Seeking Alpha


ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape
10/17/2014 8:32:00 AM - Zacks.com